A retrospective matched case-control study on medical costs of refractory migraine in Taiwan

Chao Hsiun Tang, Yong Chen Chen, Kwong Ng, Shuu Jiun Wang

研究成果: 雜誌貢獻文章

3 引文 (Scopus)

摘要

Background Migraine is associated with a significant economic burden in Western countries. However, there is limited information regarding the impact of the cost of migraine in Asia. Objectives To quantify and compare the direct medical costs of refractory migraine (RM) and other migraine, using health insurance claims data in Taiwan. Methods A retrospective matched case-control study was conducted utilizing data from the Taiwan National Health Insurance Research Database. RM cases were defined as patients with at least 1 neurological outpatient visit with a primary or secondary International Classification of Diseases, Ninth Revision, Clinical Modification code of 346.11 (common migraine with intractable migraine, so stated), diagnosed by certified neurologists in medical centers during 2007-2008. The first control group was the non-migraineurs matched with cases at a 4:1 ratio by age, gender, urbanization level of the residence, and income. The second control group was patients with other migraine types (346.00, 346.10, 346.20, 346.80, and 346.90) matched with cases at a 4:1 ratio by age, gender, and hospital setting. Medical utilization and costs within 365 days after the index visit date were assessed using a 2-part model. The exchange rate for US$1 was NT$32.50. Results Patients with RM had significantly higher total medical costs compared with non-migraineurs (NT$57,932 [US$1783] vs NT$26,817 [US$825]; P 15 headache days per month and presence of a history of migraine. Conclusions Refractory migraineurs in Taiwan had significantly higher medical costs than either non-migraineurs or those with other migraine diagnoses.

原文英語
頁(從 - 到)526-539
頁數14
期刊Headache
53
發行號3
DOIs
出版狀態已發佈 - 三月 2013

指紋

Migraine Disorders
Taiwan
Case-Control Studies
Costs and Cost Analysis
Migraine without Aura
Control Groups
Urbanization
National Health Programs
International Classification of Diseases
Health Insurance
Headache
Outpatients
Economics
Databases

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

引用此文

A retrospective matched case-control study on medical costs of refractory migraine in Taiwan. / Tang, Chao Hsiun; Chen, Yong Chen; Ng, Kwong; Wang, Shuu Jiun.

於: Headache, 卷 53, 編號 3, 03.2013, p. 526-539.

研究成果: 雜誌貢獻文章

Tang, Chao Hsiun ; Chen, Yong Chen ; Ng, Kwong ; Wang, Shuu Jiun. / A retrospective matched case-control study on medical costs of refractory migraine in Taiwan. 於: Headache. 2013 ; 卷 53, 編號 3. 頁 526-539.
@article{2181bd9be54d486f87bb1ea1aaf0b90e,
title = "A retrospective matched case-control study on medical costs of refractory migraine in Taiwan",
abstract = "Background Migraine is associated with a significant economic burden in Western countries. However, there is limited information regarding the impact of the cost of migraine in Asia. Objectives To quantify and compare the direct medical costs of refractory migraine (RM) and other migraine, using health insurance claims data in Taiwan. Methods A retrospective matched case-control study was conducted utilizing data from the Taiwan National Health Insurance Research Database. RM cases were defined as patients with at least 1 neurological outpatient visit with a primary or secondary International Classification of Diseases, Ninth Revision, Clinical Modification code of 346.11 (common migraine with intractable migraine, so stated), diagnosed by certified neurologists in medical centers during 2007-2008. The first control group was the non-migraineurs matched with cases at a 4:1 ratio by age, gender, urbanization level of the residence, and income. The second control group was patients with other migraine types (346.00, 346.10, 346.20, 346.80, and 346.90) matched with cases at a 4:1 ratio by age, gender, and hospital setting. Medical utilization and costs within 365 days after the index visit date were assessed using a 2-part model. The exchange rate for US$1 was NT$32.50. Results Patients with RM had significantly higher total medical costs compared with non-migraineurs (NT$57,932 [US$1783] vs NT$26,817 [US$825]; P 15 headache days per month and presence of a history of migraine. Conclusions Refractory migraineurs in Taiwan had significantly higher medical costs than either non-migraineurs or those with other migraine diagnoses.",
keywords = "case-control study, chronic migraine, claims data analysis, drug cost, health insurance reimbursement, health-care cost",
author = "Tang, {Chao Hsiun} and Chen, {Yong Chen} and Kwong Ng and Wang, {Shuu Jiun}",
year = "2013",
month = "3",
doi = "10.1111/head.12039",
language = "English",
volume = "53",
pages = "526--539",
journal = "Headache",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "3",

}

TY - JOUR

T1 - A retrospective matched case-control study on medical costs of refractory migraine in Taiwan

AU - Tang, Chao Hsiun

AU - Chen, Yong Chen

AU - Ng, Kwong

AU - Wang, Shuu Jiun

PY - 2013/3

Y1 - 2013/3

N2 - Background Migraine is associated with a significant economic burden in Western countries. However, there is limited information regarding the impact of the cost of migraine in Asia. Objectives To quantify and compare the direct medical costs of refractory migraine (RM) and other migraine, using health insurance claims data in Taiwan. Methods A retrospective matched case-control study was conducted utilizing data from the Taiwan National Health Insurance Research Database. RM cases were defined as patients with at least 1 neurological outpatient visit with a primary or secondary International Classification of Diseases, Ninth Revision, Clinical Modification code of 346.11 (common migraine with intractable migraine, so stated), diagnosed by certified neurologists in medical centers during 2007-2008. The first control group was the non-migraineurs matched with cases at a 4:1 ratio by age, gender, urbanization level of the residence, and income. The second control group was patients with other migraine types (346.00, 346.10, 346.20, 346.80, and 346.90) matched with cases at a 4:1 ratio by age, gender, and hospital setting. Medical utilization and costs within 365 days after the index visit date were assessed using a 2-part model. The exchange rate for US$1 was NT$32.50. Results Patients with RM had significantly higher total medical costs compared with non-migraineurs (NT$57,932 [US$1783] vs NT$26,817 [US$825]; P 15 headache days per month and presence of a history of migraine. Conclusions Refractory migraineurs in Taiwan had significantly higher medical costs than either non-migraineurs or those with other migraine diagnoses.

AB - Background Migraine is associated with a significant economic burden in Western countries. However, there is limited information regarding the impact of the cost of migraine in Asia. Objectives To quantify and compare the direct medical costs of refractory migraine (RM) and other migraine, using health insurance claims data in Taiwan. Methods A retrospective matched case-control study was conducted utilizing data from the Taiwan National Health Insurance Research Database. RM cases were defined as patients with at least 1 neurological outpatient visit with a primary or secondary International Classification of Diseases, Ninth Revision, Clinical Modification code of 346.11 (common migraine with intractable migraine, so stated), diagnosed by certified neurologists in medical centers during 2007-2008. The first control group was the non-migraineurs matched with cases at a 4:1 ratio by age, gender, urbanization level of the residence, and income. The second control group was patients with other migraine types (346.00, 346.10, 346.20, 346.80, and 346.90) matched with cases at a 4:1 ratio by age, gender, and hospital setting. Medical utilization and costs within 365 days after the index visit date were assessed using a 2-part model. The exchange rate for US$1 was NT$32.50. Results Patients with RM had significantly higher total medical costs compared with non-migraineurs (NT$57,932 [US$1783] vs NT$26,817 [US$825]; P 15 headache days per month and presence of a history of migraine. Conclusions Refractory migraineurs in Taiwan had significantly higher medical costs than either non-migraineurs or those with other migraine diagnoses.

KW - case-control study

KW - chronic migraine

KW - claims data analysis

KW - drug cost

KW - health insurance reimbursement

KW - health-care cost

UR - http://www.scopus.com/inward/record.url?scp=84875258691&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875258691&partnerID=8YFLogxK

U2 - 10.1111/head.12039

DO - 10.1111/head.12039

M3 - Article

C2 - 23406446

AN - SCOPUS:84875258691

VL - 53

SP - 526

EP - 539

JO - Headache

JF - Headache

SN - 0017-8748

IS - 3

ER -